Sensex Today | Stock Market LIVE Updates: Nifty abve 23,700; Caplin Point surges 10%
Cipla's shares were among the top gainers in the market on May 11, 2026, increasing by 6.63% to ₹1,415.60, as reported in a live stock market update.
May 14 2026 14:05:00
Sensex Today | Stock Market LIVE Updates: Sensex soars 1,000 points, Nifty above 23,700
Cipla shares rose 8% despite reporting disappointing Q4 results. The rally is being driven by other factors influencing the pharmaceutical stock.
May 14 2026 14:05:00
Sensex Today | Stock Market LIVE Updates: Nifty holds 300-point gain; Apollo Hospital at 52-week high
Cipla reported a 55% year-on-year decline in Q4 FY26 consolidated net profit to ₹554.6 crore and a 2.8% fall in revenue to ₹6,541.2 crore. Despite the weak financial performance, the company's shares surged over 7.9% on May 14, 2026, driven by optimistic management commentary regarding future growth, particularly a target of $1 billion in annual US sales by the end of FY27. Additionally, the board recommended a final dividend of ₹13 per equity share for FY26.
May 14 2026 14:05:00
Sensex Today | Stock Market LIVE Updates: Nifty extends gains, surges past 23,750 mark, Sensex up 1,000 pts
Indian equities saw a rally, with the Nifty 50 and Sensex gaining significantly. Cipla Limited's stock price increased by approximately 6.8% amidst this broader market positive movement.
May 14 2026 13:05:00
Sensex Today | Stock Market LIVE Updates: Nifty marks a sharp recovery from falls, nears day's high
Cipla's shares soared 8% despite reporting disappointing Q4 results, driven by investor optimism regarding the company's strategic expansion plans, including potential acquisitions in the South African drug market and an ambitious target to achieve $1 billion in US revenue by FY27.
May 14 2026 11:05:00
Sensex Today | Stock Market LIVE Updates: Nifty IT extends losses to 700 points, minor recovery in mkt
Cipla's stock surged 8% driven by the company's strategic outlook, which includes plans for acquisitions to secure a leading position in the South African drug market and an aspiration to achieve $1 billion in US revenue by FY27. This positive market reaction occurred despite what was described as a disappointing fourth-quarter performance.
May 14 2026 11:05:00
Sensex Today | Stock Market LIVE Updates: Nifty falls to 23,400; Midcap, Banking, Sensex slump to turn negative
The article provides live updates on the stock market, covering movements of various indices and individual stocks. Cipla's stock performance is noted within the context of overall market and sector trends, reflecting general market sentiment rather than a specific corporate event.
May 14 2026 11:05:00
Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked target
Cipla's shares rallied 8% despite a reported 55% year-on-year slump in Q4 net profit, as several brokerages, including Citi and Nuvama, either upgraded ratings or hiked target prices. Analysts cited strong future growth prospects from branded prescription sales, market share gains, and new product launches in key markets as reasons for their optimism.
May 14 2026 11:05:00
Cipla shares jump 7% after at least six analyst upgrades on Q4 results, outlook
Cipla's shares rallied following multiple analyst upgrades, driven by a positive outlook for the company's upcoming Q4 results and a robust US business pipeline, including potential from generic Advair and gRevlimid.
May 14 2026 09:05:00
Cipla Limited
Cipla Limited appointed Mr. Sushrut Kulkarni as President & Global Chief – Integrated Product Development, effective May 18, 2026. He joins the Management Council as Senior Management Personnel, bringing over 30 years of experience from Dr Reddy’s Laboratories.
May 13 2026 20:05:00
Read More